SLC16A1 and cancer: Overall, SLC16A1-AS1-induced cancer progression is not mediated merely by SLC16A1 upregulation, but also orchestrated via systemic changes in additional targets and pathways, of which PPARA is a SLC16A1-AS1 responsive gene that can follow a mechanism of transactivation similar to the one identified for SLC16A1.